Contraceptive Agents, Female

Displaying 1 - 3 of 3CSV
Mugo, N. R., Stalter, R. M., Heffron, R., Rees, H., Scoville, C. W., Morrison, C., Kourtis, A. P., Bukusi, E., Beksinska, M., Philip, N. M., Beesham, I., Deese, J., Edward, V., Donnell, D., Baeten, J. M., Baeten, J. M., Kiarie, J., Mastro, T. D., … Welch, J. D. (2021). Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. Clinical Infectious Diseases, 75(4), 586–595. https://doi.org/10.1093/cid/ciab1027
Publication Date
Fang, N. Z., & Westhoff, C. L. (2022). Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States. American Journal of Obstetrics and Gynecology, 227(3), 477.e1-477.e7. https://doi.org/10.1016/j.ajog.2022.05.021
Publication Date
Palanee-Phillips, T., Rees, H. V., Heller, K. B., Ahmed, K., Batting, J., Beesham, I., Heffron, R., Justman, J., Makkan, H., Mastro, T. D., Morrison, S. A., Mugo, N., Nair, G., Kiarie, J., Philip, N. M., Pleaner, M., Reddy, K., Selepe, P., … Steyn, P. S. (2022). High HIV incidence among young women in South Africa: Data from a large prospective study. PLOS ONE, 17(6), e0269317. https://doi.org/10.1371/journal.pone.0269317
Publication Date